Your browser doesn't support javascript.
loading
Enhanced Immunohistochemistry Interpretation with a Machine Learning-Based Expert System.
Neagu, Anca Iulia; Poalelungi, Diana Gina; Fulga, Ana; Neagu, Marius; Fulga, Iuliu; Nechita, Aurel.
Afiliación
  • Neagu AI; Faculty of Medicine and Pharmacy, Dunarea de Jos University of Galati, 35 AI Cuza St., 800010 Galati, Romania.
  • Poalelungi DG; Saint John Clinical Emergency Hospital for Children, 800487 Galati, Romania.
  • Fulga A; Faculty of Medicine and Pharmacy, Dunarea de Jos University of Galati, 35 AI Cuza St., 800010 Galati, Romania.
  • Neagu M; Saint Apostle Andrew Emergency County Clinical Hospital, 177 Brailei St., 800578 Galati, Romania.
  • Fulga I; Faculty of Medicine and Pharmacy, Dunarea de Jos University of Galati, 35 AI Cuza St., 800010 Galati, Romania.
  • Nechita A; Saint Apostle Andrew Emergency County Clinical Hospital, 177 Brailei St., 800578 Galati, Romania.
Diagnostics (Basel) ; 14(17)2024 Aug 24.
Article en En | MEDLINE | ID: mdl-39272638
ABSTRACT

BACKGROUND:

In recent decades, machine-learning (ML) technologies have advanced the management of high-dimensional and complex cancer data by developing reliable and user-friendly automated diagnostic tools for clinical applications. Immunohistochemistry (IHC) is an essential staining method that enables the identification of cellular origins by analyzing the expression of specific antigens within tissue samples. The aim of this study was to identify a model that could predict histopathological diagnoses based on specific immunohistochemical markers.

METHODS:

The XGBoost learning model was applied, where the input variable (target variable) was the histopathological diagnosis and the predictors (independent variables influencing the target variable) were the immunohistochemical markers.

RESULTS:

Our study demonstrated a precision rate of 85.97% within the dataset, indicating a high level of performance and suggesting that the model is generally reliable in producing accurate predictions.

CONCLUSIONS:

This study demonstrated the feasibility and clinical efficacy of utilizing the probabilistic decision tree algorithm to differentiate tumor diagnoses according to immunohistochemistry profiles.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Diagnostics (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Rumanía Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Diagnostics (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Rumanía Pais de publicación: Suiza